Johnson & Johnson (NYSE:JNJ) Position Reduced by Pavion Blue Capital LLC
Pavion Blue Capital LLC decreased its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,690 shares of the company’s stock after selling 124 shares during the quarter. Johnson & Johnson makes up 2.8% […]
More Stories
BigBear.ai (NYSE:BBAI) Trading Down 2.4% – What’s Next?
BigBear.ai Holdings, Inc. (NYSE:BBAI – Get Free Report)’s share price traded down 2.4% on Friday . The stock traded as...
Klondike Silver (CVE:KS) Stock Price Down 33.3% – What’s Next?
Klondike Silver Corp. (CVE:KS – Get Free Report)’s stock price fell 33.3% during trading on Friday . The company traded...
Microbot Medical (NASDAQ: MBOT) Announces $8.6 Million Registered Direct Offering
Microbot Medical Inc., a Delaware corporation, has recently disclosed an agreement involving Securities Purchase Agreements with investors for a registered...
La Rosa Holdings Corp. Completes Acquisition of Baxpi and Beaches Franchisees
La Rosa Holdings Corp. (NASDAQ: LRHC) recently announced the completion of its acquisition of Baxpi Holdings LLC and La Rosa...
NextCure Initiates Phase 1 Study for B7-H4 ADC Therapy to Treat Multiple Cancers_
On January 10, 2025, NextCure, Inc. (NASDAQ: NXTC) made a significant announcement through a press release, indicating the dosing of...
ImmuCell Announces Strong Preliminary Sales Results for Q4 and Full Year 2024
ImmuCell Corporation (NASDAQ: ICCC) recently disclosed its preliminary, unaudited sales figures for the fourth quarter and full year that ended...